cetylpyridinium chloride anhydrous has been researched along with Severe Acute Respiratory Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Disthakumpa, A; Moolasart, V; Srijareonvijit, C; Srikirin, P; Uttayamakul, S; Vaivong, N; Wongsawat, J | 1 |
Pearson, H | 1 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and Severe Acute Respiratory Syndrome
Article | Year |
---|---|
Risk of novel coronavirus 2019 transmission from children to caregivers: A case series.
Topics: Caregivers; Child; Child, Preschool; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Disease Outbreaks; Health; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Male; Pandemics; Pneumonia, Viral; Retrospective Studies; Risk Assessment; Sampling Studies; Severe Acute Respiratory Syndrome; Taiwan; World Health Organization | 2020 |
Antibodies to SARS-like virus hint at repeated infections.
Topics: Animals; Antibodies, Viral; China; Health; Hong Kong; Humans; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Zoonoses | 2004 |